Across
- 4. Routinely administered in TTP management to suppress autoimmune production of anti-ADAMTS13 antibodies)
- 6. Type of anaemia caused by TTP
- 8. An anti-CD20 monoclonal antibody recommended in cases with suboptimal response to first line, or in for those at high risk of relapse
- 9. As the problem is in the small vessels, TTP is a?
Down
- 1. Mainstay of treatment (2 words)
- 2. The nature of neurological manifestations in TTP (come and go)
- 3. A haematological condition which overlaps with TTP
- 5. Develop in the small vessels in TTP
- 7. A metalloprotease enzyme, of which there is a deficiency in TTP
